case_images: PMC11250497_01
case_images: Colored fundus photo showing superior and temporal subretinal triamcinolone acetonide deposits on day 0.
case_images: cop-2024-0015-0001-539190_F01.jpg
case_images: PMC11250497_01_cop-2024-0015-0001-539190_F01.jpg
case_images: F1
case_images: TA in the vitreous cavity (Fig. 1).
case_images: Colored fundus photo showing almost full resolution the subretinal triamcinolone acetonide deposits after 3 months. Only few deposits remain in the temporal peripheral retina.
case_images: cop-2024-0015-0001-539190_F02.jpg
case_images: PMC11250497_01_cop-2024-0015-0001-539190_F02.jpg
case_images: F2
case_images: Hg after the anterior chamber tap was done. The patient's axial length was 24.88 mm OD and 25.66 mm OS (SB still in place). The patient was followed up 1 week, 1 month, and 3 months after the procedure and the retina remained attached with complete resolution of the CME and decrease in the subretinal Kenalog (Fig. 2, 3). His uncorrected visual acuity improved from 20/100 to 20/70 and his intraocular pressures remained normal.
case_images: OCT of the macula showing cystoid macular edema (CME) before the injection of triamcinolone acetonide (TA) above and after injection of TA below with resolution of CME and some outer retinal changes. The epiretinal membrane remained stable.
case_images: cop-2024-0015-0001-539190_F03.jpg
case_images: PMC11250497_01_cop-2024-0015-0001-539190_F03.jpg
case_images: F3
case_images: Hg after the anterior chamber tap was done. The patient's axial length was 24.88 mm OD and 25.66 mm OS (SB still in place). The patient was followed up 1 week, 1 month, and 3 months after the procedure and the retina remained attached with complete resolution of the CME and decrease in the subretinal Kenalog (Fig. 2, 3). His uncorrected visual acuity improved from 20/100 to 20/70 and his intraocular pressures remained normal.